Literature DB >> 21278066

Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNFα monoclonal antibodies.

Srilakshmi M Sharma, Tammy M Martin, Carlos D Rosé, Andrew D Dick, Athimalaipet V Ramanan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21278066      PMCID： PMC3077914          DOI： 10.1093/rheumatology/keq431

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

Review 1.  NOD-like receptors: ancient sentinels of the innate immune system.

Authors:  P Rosenstiel; G Jacobs; A Till; S Schreiber
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

2.  The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity.

Authors:  Tammy M Martin; Zili Zhang; Paul Kurz; Carlos D Rosé; Hong Chen; Huiying Lu; Stephen R Planck; Michael P Davey; James T Rosenbaum
Journal:  Arthritis Rheum       Date:  2009-02

Review 3.  Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease.

Authors:  J H Chang; P J McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 4.  NOD-like receptors--pivotal guardians of the immunological integrity of barrier organs.

Authors:  Philip Rosenstiel; Stefan Schreiber
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

5.  CARD15 mutations in Blau syndrome.

Authors:  C Miceli-Richard; S Lesage; M Rybojad; A M Prieur; S Manouvrier-Hanu; R Häfner; M Chamaillard; H Zouali; G Thomas; J P Hugot
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

6.  The etiologic role of infectious antigens in sarcoidosis pathogenesis.

Authors:  Kyra A Oswald-Richter; Wonder P Drake
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

Review 7.  Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities.

Authors:  D A Lewinsohn; M L Gennaro; L Scholvinck; D M Lewinsohn
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

8.  Familial granulomatous synovitis, uveitis, and cranial neuropathies.

Authors:  D A Jabs; J L Houk; W B Bias; F C Arnett
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965

9.  Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

Authors:  Ikuo Okafuji; Ryuta Nishikomori; Nobuo Kanazawa; Naotomo Kambe; Akihiro Fujisawa; Shin Yamazaki; Megumu Saito; Takakazu Yoshioka; Tomoki Kawai; Hidemasa Sakai; Hideaki Tanizaki; Toshio Heike; Yoshiki Miyachi; Tatsutoshi Nakahata
Journal:  Arthritis Rheum       Date:  2009-01

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258
  10 in total
  8 in total

Review 1.  Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.

Authors:  Francesco La Torre; Giovanni Lapadula; Luca Cantarini; Orso Maria Lucherini; Florenzo Iannone
Journal:  Clin Rheumatol       Date:  2014-01-21       Impact factor: 2.980

Review 2.  The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors:  Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-02       Impact factor: 2.980

3.  Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis.

Authors:  Marino Achille; Pagnini Ilaria; Giani Teresa; Caputo Roberto; Arapi Ilir; Neri Piergiorgio; Cimaz Rolando; Simonini Gabriele
Journal:  Int Ophthalmol       Date:  2015-10-08       Impact factor: 2.031

Review 4.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

5.  Blau Syndrome and Early-Onset Sarcoidosis: A Six Case Series and Review of the Literature.

Authors:  Ayşenur PaÇ Kisaarslan; Betül SÖzerİ; Nihal Şahİn; Sümeyra Özdemİr ÇİÇek; Zübeyde GÜndÜz; Erkan Demİrkaya; Afig Berdelİ; Serdal Sadet Özcan; Hakan PorazoĞlu; Ruhan DÜŞÜnsel
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

Review 6.  Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature.

Authors:  Yusuke Takeuchi; Tomonari Shigemura; Norimoto Kobayashi; Naoe Kaneko; Tomoyuki Iwasaki; Kisei Minami; Keiko Kobayashi; Junya Masumoto; Kazunaga Agematsu
Journal:  Clin Rheumatol       Date:  2017-01-27       Impact factor: 3.650

Review 7.  Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Authors:  Antonio Vitale; Donato Rigante; Orso Maria Lucherini; Francesco Caso; Isabella Muscari; Flora Magnotti; Maria Giuseppina Brizi; Susanna Guerrini; Maria Patti; Leonardo Punzi; Mauro Galeazzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

8.  Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome.

Authors:  Jing Chen; Yi Luo; Mengzhu Zhao; Di Wu; Yunjiao Yang; Wen Zhang; Min Shen
Journal:  Arthritis Res Ther       Date:  2019-11-12       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.